Bio-Techne TECH Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $1.21B-0.4% | $1.22B-0.1% | $1.22B-0.2% | $1.22B+0.9% | $1.21B+1.1% | ||
| $424.32M+0.4% | $422.82M+0.3% | $421.37M-1.9% | $429.36M+3.7% | $413.96M+0.7% | ||
| $786.49M-0.8% | $792.76M-0.3% | $795.37M+0.6% | $790.27M-0.6% | $794.81M+1.3% | ||
| 65%-0.3pp | 65.2%-0.2pp | 65.4%+0.6pp | 64.8%-1.0pp | 65.8%+0.1pp | ||
| $96.85M-1.1% | $97.98M-1.9% | $99.87M+0.4% | $99.5M+2.1% | $97.45M-1.2% | ||
| $535.88M-7.3% | $577.81M-1.3% | $585.57M-0.5% | $588.52M+12.0% | $525.42M+8.1% | ||
| $632.74M-6.4% | $675.79M-1.4% | $685.44M-0.4% | $688.02M+10.5% | $622.87M+6.5% | ||
| $632.74M-6.4% | $675.79M-1.4% | $685.44M-0.4% | $688.02M+10.5% | $622.87M+6.5% | ||
| —— | —— | —— | —— | $171.94M-14.1% | ||
| —— | —— | —— | $8.51M-17.5% | $10.32M-14.9% | ||
| —— | —— | —— | $3.89M+3.8% | $3.75M+3.9% | ||
| —— | —— | —— | —— | -$8.96M+38.0% | ||
| —— | —— | —— | —— | $162.98M-12.3% | ||
| —— | —— | —— | —— | $31.32M+13.2% | ||
| —— | —— | —— | —— | $131.67M-16.7% | ||
| —— | —— | —— | —— | $0.83-17.0% | ||
| —— | —— | —— | —— | $0.83-17.0% | ||
| 630.5M-0.2% | 632M-0.6% | 635.6M-0.7% | 640.4M-0.2% | 641.5M-0.2% | ||
| 625.2M-0.2% | 626.2M-0.4% | 628.8M-0.5% | 631.9M0.0% | 632M0.0% | ||
| —— | —— | —— | $3.89M+3.8% | $3.75M+3.9% | ||
| $124.76M+19.5% | $104.41M+41.7% | $73.68M-19.8% | $91.84M-26.5% | $124.92M-8.2% | ||
| -$3.32M+31.9% | -$4.87M-15.8% | -$4.2M+24.5% | -$5.57M+5.0% | -$5.86M-53.7% | ||
| $15.2M-34.8% | $23.31M+641% | -$4.31M-123% | $18.44M+373% | -$6.75M+69.3% | ||
| —— | —— | —— | $831K+155% | -$1.52M+60.7% | ||
| $96.85M-1.1% | $97.98M-1.9% | $99.87M+0.4% | $99.5M+2.1% | $97.45M-1.2% | ||
| $1.21B-0.4% | $1.22B-0.1% | $1.22B-0.2% | $1.22B+0.9% | $1.21B+1.1% | ||
| —— | —— | —— | —— | $171.94M-14.1% | ||
| —— | —— | —— | —— | $282.79M-9.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Techne's revenue?
- Bio-Techne (TECH) generated $1.2B in revenue over the trailing twelve months, up 0.2% year over year.
- Is Bio-Techne profitable?
- Bio-Techne reported $149.8M in net income over the trailing twelve months, a 10.9% net margin.
- What are Bio-Techne's profit margins?
- Gross margin is 65.0% and operating margin is 14.2%, with a 10.9% net margin.
- What is Bio-Techne's earnings per share?
- Bio-Techne's diluted EPS over the trailing twelve months is $0.94.
- Where does Bio-Techne's income statement data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
